Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015.

ABSTRACT:

Importance

Drug company payments to health care organizations can create conflicts of interest. However, little is known about such financial relationships, especially outside the United States.

Objective

To examine the concentration and patterns of drug company payments to health care organizations in the United Kingdom.

Design, setting, and participants

This cross-sectional study examined nonresearch payments reported in the industry-run Disclosure UK database. Companies participating in Disclosure UK in 2015 and health care organizations receiving their payments were included in the analysis. The data were analyzed descriptively at the health care organization, payment, and donor levels, considering health care organization categories, payment categories, and compa

SUBMITTER: Ozieranski P 

PROVIDER: S-EPMC6593961 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature